The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Strategy for Treatment of Infected Diabetic Foot Ulcers
Abstract
Conspectus Diabetic foot ulcers (DFUs) are chronic wounds that develop in 30% of diabetic patients. In DFUs, the normal wound healing process consisting of inflammation, angiogenesis, and extracellular matrix (ECM) remodeling is dysregulated and stalled. Upon injury, neutrophils and monocytes arrive at the wound and secrete matrix metalloproteinase (MMP)-8 and reactive oxygen species (ROS). ROS activates nuclear factor kappa beta (NF-κB), which upregulates MMP-9. Monocytes become macrophages, secreting tumor growth factor (TGF)-β1 and vascular endothelial growth factor (VEGF) for angiogenesis, resulting in remodeling of the ECM. MMP-9 cleaves laminin for keratinocyte migration. MMP-8 is beneficial for remodeling the ECM and healing the wound. In DFUs, the excess unregulated MMP-9 is detrimental, destroying the ECM and preventing the wound from healing. DFUs are typically infected, many with biofilm-producing bacteria that are resistant to antibiotics. Infection increases the time for wound healing and the likelihood for a lower-limb amputation. Despite the use of antibiotics, amputations occur in 24.5% of patients with DFUs. Clearly, new strategies for treatment of DFUs are needed. With the use of an affinity resin that binds exclusively to the active forms of MMPs and proteomics, we identified two proteinases, MMP-8 and MMP-9, in wounds of diabetic mice and diabetic humans. With the use of selective inhibitors, gene ablation of MMP-9, and exogenous application of MMP-8, we demonstrated that MMP-8 is beneficial to wound repair and that MMP-9 prevents the diabetic wound from healing. Our research has shown that infection increases active MMP-9, increasing inflammation and decreasing angiogenesis. As a result, infected diabetic wounds take a longer time to heal than uninfected ones. We found that active MMP-9 and NF-κB increased in human DFUs with wound severity and infection. The best strategy for treatment of DFUs is to selectively inhibit the detrimental proteinase MMP-9 without affecting the beneficial MMP-8 so that the body can repair the wound. Lead optimization of the thiirane class of inhibitors led to the discovery of ( R )-ND-336, a potent (19 nM) and selective (450-fold) MMP-9 inhibitor. ( R )-ND-336 accelerated wound healing in diabetic mice by decreasing ROS and NF-κB, lowering inflammation, and increasing angiogenesis. ( R )-ND-336 in combination with the antibiotic linezolid improved wound healing in infected diabetic mice by inhibiting MMP-9, which mitigated macrophage infiltration and increased angiogenesis, thereby restoring the normal wound healing process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas
Szkudelski, T. (2001) · Physiological Research · doi:10.33549/physiolres.930111 · Cited by 2,876
James, G. A., Swogger, E., Wolcott, R., Pulcini, E. D., Secor, P., Sestrich, J., Costerton, J. W., & Stewart, P. S. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00321.x · Cited by 1,543
The Dysvascular Foot: A System for Diagnosis and Treatment
Wagner, F. W. (1981) · Foot & Ankle · doi:10.1177/107110078100200202 · Cited by 1,107
Nissen, N., Polverini, P. J., Koch, A. E., Volin, M. V., Gamelli, R. L., & DiPietro, L. A. (1998) · Europe PMC (PubMed Central) · Cited by 842
Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., & Opdenakker, G. (2000) · Blood · doi:10.1182/blood.v96.8.2673 · Cited by 680
Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease
Yabluchanskiy, A., Ma, Y., Iyer, R. P., Hall, M. E., & Lindsey, M. L. (2013) · Physiology · doi:10.1152/physiol.00029.2013 · Cited by 635
IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes
Lipsky, B. A., Aragón‐Sánchez, J., Diggle, M., Embil, J., Kono, S., Lavery, L., Senneville, É., Urbančič‐Rovan, V., Van Asten, S., & on behalf of the International Working Group on the Diabetic Foot (IWGDF) (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2699 · Cited by 568
T cell gelatinases mediate basement membrane transmigration in vitro.
Leppert, D., Waubant, E., Galardy, R., Bunnett, N. W., & Hauser, S. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4379 · Cited by 492
A Comparison of Two Diabetic Foot Ulcer Classification Systems
Oyibo, S. O., Jude, E. B., Tarawneh, I., Nguyen, H. C., Harkless, L. B., & Boulton, A. J. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.84 · Cited by 468
The Role of Matrix Metalloproteinases in Wound Healing
Armstrong, D. G., & Jude, E. B. (2002) · Journal of the American Podiatric Medical Association · doi:10.7547/87507315-92-1-12 · Cited by 350
The paradox of matrix metalloproteinases in infectious disease
Elkington, P. T. G., O'Kane, C. M., & Friedland, J. S. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02840.x · Cited by 340
APELQVIST, J., RAGNARSON‐TENNVALL, G., LARSSON, J., & PERSSON, U. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01104.x · Cited by 305
Olson, M. W., Gervasi, D. C., Mobashery, S., & Fridman, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29975 · Cited by 288
Increased inflammation delays wound healing in mice deficient in collagenase‐2 (MMP‐8)
Gutiérrez-Fernández, A., Inada, M., Balbín, M., Fueyo, A., Pitiot, A. S., Astudillo, A., Hirose, K., Hirata, M., Shapiro, S. D., Noël, A., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7860com · Cited by 281
Grobelny, D., Poncz, L., & Galardy, R. E. (1992) · Biochemistry · doi:10.1021/bi00146a017 · Cited by 273
Matrix Metalloproteinases Contribute to Brain Damage in Experimental Pneumococcal Meningitis
Leib, S. L., Leppert, D., Clements, J., & Täuber, M. G. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.615-620.2000 · Cited by 259
Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact
Hartemann‐Heurtier, A., Robert, J., Jacqueminet, S., Ha Van, G., Golmard, J. L., Jarlier, V., & Grimaldi, A. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01237.x · Cited by 223
McCawley, L. J., O'Brien, P., & Hudson, L. G. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199808)176:2<255::aid-jcp4>3.0.co;2-n · Cited by 215
Acceleration of diabetic wound healing using a novel protease–anti-protease combination therapy
Gao, M., Nguyen, T. T., Suckow, M. A., Wolter, W. R., Gooyit, M., Mobashery, S., & Chang, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517847112 · Cited by 182
Self-citationPGE2-induced metalloproteinase-9 is essential for dendritic cell migration
Yen, J.-H., Khayrullina, T., & Ganea, D. (2008) · Blood · doi:10.1182/blood-2007-05-090613 · Cited by 163
Low Molecular Weight Inhibitors in Corneal Ulcerationa
GALARDY, R. E., CASSABONNE, M. E., GIESE, C., GILBERT, J. H., LAPIERRE, F., LOPEZ, H., SCHAEFER, M. E., STACK, R., SULLIVAN, M., SUMMERS, B., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24746.x · Cited by 159
van Battum, P. L. H., Schaper, N. C., Prompers, L., Apelqvist, J., Jude, E. B., Piaggesi, A., Bakker, K., EDMONDS, M. E., Holstein, P., Jirkovská, A., et al. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03192.x · Cited by 157
Production of Matrix Metalloproteinases in Response to Mycobacterial Infection
Quiding‐Järbrink, M., Smith, D. A., & Bancroft, G. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.9.5661-5670.2001 · Cited by 154
Nguyen, T. T., Ding, D., Wolter, W. R., Pérez, R. L., Champion, M. M., Mahasenan, K. V., Hesek, D., Lee, M., Schroeder, V. A., Jones, J. I., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01005 · Cited by 149
Self-citationMicrobiological profile of infected diabetic foot ulcers
Y.Ge, D. M., Hait, H. I., Lipsky, B. A., ZASLOFF, M. A., & Holroyd, K. J. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00696_1.x · Cited by 142
Potent Mechanism-based Inhibitors for Matrix Metalloproteinases
Ikejiri, M., Bernardo, M. M., Bonfil, R. D., Tóth, M., Chang, M., Fridman, R. A., & Mobashery, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504303200 · Cited by 136
Self-citationModels for the study of skin wound healing. The role of Nrf2 and NF-κB
Ambrožová, N., Ulrichová, J., & Galandáková, A. (2017) · Biomedical Papers · doi:10.5507/bp.2016.063 · Cited by 122
Ågren, M. S., Mirastschijski, U., Karlsmark, T., & Saarialho‐Kere, U. (2001) · Experimental Dermatology · doi:10.1034/j.1600-0625.2001.100506.x · Cited by 121
Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers
Richard, J.-L., Sotto, A., Jourdan, N., Combescure, C., Vannereau, D., Rodier, M., & Lavigne, J. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.02.005 · Cited by 120
Targeting MMP-9 in Diabetic Foot Ulcers
Jones, J. I., Nguyen, T. T., Peng, Z., & Chang, M. (2019) · Pharmaceuticals · doi:10.3390/ph12020079 · Cited by 114
Self-citationArylamine N-acetyltransferases – of mice, men and microorganisms
Upton, A. M., Johnson, N., Sandy, J., & Sim, E. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01639-4 · Cited by 113
A Chemical Biological Strategy to Facilitate Diabetic Wound Healing
Gooyit, M., Peng, Z., Wolter, W. R., Pi, H., Ding, D., Hesek, D., Lee, M., Boggess, B., Champion, M. M., Suckow, M. A., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb4005468 · Cited by 103
Self-citationWound Healing - New insights into Ancient Challenges
Alexandrescu, V.-A. (2016) · InTech eBooks · doi:10.5772/61906 · Cited by 98
Pochetti, G., Montanari, R., Gege, C., Chevrier, C., Taveras, A. G., & Mazza, F. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801166j · Cited by 82
Factors affecting lifespan following below-knee amputation in diabetic patients
Beyaz, S., Güler, Ü. Ö., & Bağır, G. Ş. (2017) · Acta Orthopaedica et Traumatologica Turcica · doi:10.1016/j.aott.2017.07.001 · Cited by 76
Hui, L., Nie, Y., Li, S., Guo, M., Yang, W. Z., Huang, R., Chen, J., Liu, Y., Lu, X., Chen, Z., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008509 · Cited by 75
Prostate Cancer-Associated Membrane Type 1-Matrix Metalloproteinase
Bonfil, R. D., Dong, Z., Filho, J. C. T., Sabbota, A. L., Osenkowski, P., Nabha, S. M., Yamamoto, H., Chinni, S. R., Zhao, H., Mobashery, S., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060720 · Cited by 72
Active Site Ring‐Opening of a Thiirane Moiety and Picomolar Inhibition of Gelatinases
Forbes, C. C., Shi, Q., Fisher, J. F., Lee, M., Hesek, D., Llarrull, L. I., Tóth, M., Gossing, M., Fridman, R. A., & Mobashery, S. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00881.x · Cited by 59
Selective Water-Soluble Gelatinase Inhibitor Prodrugs
Gooyit, M., Lee, M., Schroeder, V. A., Ikejiri, M., Suckow, M. A., Mobashery, S., & Chang, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200566e · Cited by 54
Self-citationDesign, Synthesis, and Evaluation of a Mechanism-Based Inhibitor for Gelatinase A
Ikejiri, M., Bernardo, M. M., Meroueh, S. O., Brown, S., Chang, M., Fridman, R. A., & Mobashery, S. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo050339+ · Cited by 41
Self-citationMetabolism of a Highly Selective Gelatinase Inhibitor Generates Active Metabolite
Lee, M., Villegas‐Estrada, A., Celenza, G., Boggess, B., Tóth, M., Kreitinger, G., Forbes, C. C., Fridman, R. A., Mobashery, S., & Chang, M. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00577.x · Cited by 41
Self-citationPeng, Z., Nguyen, T. T., Song, W., Anderson, B., Wolter, W. R., Schroeder, V. A., Hesek, D., Lee, M., Mobashery, S., & Chang, M. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00104 · Cited by 39
Self-citationGooyit, M., Song, W., Mahasenan, K. V., Lichtenwalter, K., Suckow, M. A., Schroeder, V. A., Wolter, W. R., Mobashery, S., & Chang, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401217d · Cited by 36
Self-citationA Potent Gelatinase Inhibitor with Anti‐Tumor‐Invasive Activity and its Metabolic Disposition
Lee, M., Celenza, G., Boggess, B., Blase, J. R., Shi, Q., Tóth, M., Bernardo, M. M., Wolter, W. R., Suckow, M. A., Hesek, D., et al. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00750.x · Cited by 34
Self-citationNguyen, T. T., Jones, J. I., Wolter, W. R., Pérez, R. L., Schroeder, V. A., Champion, M. M., Hesek, D., Lee, M., Suckow, M. A., Mobashery, S., et al. (2019) · Wound Repair and Regeneration · doi:10.1111/wrr.12782 · Cited by 31
Self-citationWater-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury
Lee, M., Chen, Z., Tomlinson, B. N., Gooyit, M., Hesek, D., Juárez, M. R., Nizam, R., Boggess, B., Lastochkin, E., Schroeder, V. A., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00140 · Cited by 27
Self-citationGooyit, M., Lee, M., Hesek, D., Boggess, B., Oliver, A. G., Fridman, R. A., Mobashery, S., & Chang, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00898.x · Cited by 17
Self-citationCharacterization of a selective inhibitor for matrix metalloproteinase-8 (MMP-8)
Ding, D., Lichtenwalter, K., Pi, H., Mobashery, S., & Chang, M. (2014) · MedChemComm · doi:10.1039/c4md00172a · Cited by 11
Self-citationSong, W., Peng, Z., Gooyit, M., Suckow, M. A., Schroeder, V. A., Wolter, W. R., Lee, M., Ikejiri, M., Cui, J., Gu, Z., et al. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400077d · Cited by 11
Self-citation
Cited by
Diabetic Wound-Healing Science
Burgess, J. L., Wyant, W. A., Abdo Abujamra, B., Kirsner, R. S., & Jozic, I. (2021) · Medicina · doi:10.3390/medicina57101072 · Cited by 928
Supramolecular Adhesive Hydrogels for Tissue Engineering Applications
Zhao, Y., Song, S., Ren, X., Zhang, J., Lin, Q., & Zhao, Y. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00815 · Cited by 711
Anti‐inflammatory hydrogel dressings and skin wound healing
Huang, C., Dong, L., Zhao, B., Lu, Y., Huang, S., Yuan, Z., Luo, G., Xu, Y., & Qian, W. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1094 · Cited by 445
The initiation of oxidative stress and therapeutic strategies in wound healing
Wang, G., Yang, F., Zhou, W., Xiao, N., Luo, M., & Tang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114004 · Cited by 415
Xiong, Y., Lin, Z., Bu, P., Yu, T., Endo, Y., Zhou, W., Sun, Y., Cao, F., Dai, G., Hu, Y., et al. (2023) · Advanced Materials · doi:10.1002/adma.202212300 · Cited by 370
Metadata
- Authors
- Chang, M., & Nguyen, T. T.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-02-17
- Volume
- 54
- Issue
- 5
- Pages
- 1080-1093
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W3133005132
- Cited by
- 712
- References
- 51
- FWCI
- 40.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.